Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma.

PHASE3CompletedINTERVENTIONAL
Enrollment

274

Participants

Timeline

Start Date

October 1, 2002

Study Completion Date

July 15, 2005

Conditions
MelanomaNeoplasm Metastasis
Interventions
DRUG

CC-5013

Trial Locations (49)

2050

Royal Prince Alfred Hospital, Camperdown

2145

Sydney Cancer Centre, Camperdown

Westmead Hospital, Westmead

2300

Royal Newcastle Hospital, Newcastle

2605

The Canberra Hospital, Garran

3115

Kiev City Oncology Hospital, Kiev

3144

Cabrini Hospital, Malvern

4001

Addington Hospital, Durban

Durban Oncology Centre, Westridge, Durban

4029

Roayl Brisbane Hospital, Herston

4102

Princess Alexandra Hospital, Woolloongabba

5000

Royal Adelaide Hospital, Adelaide

6001

St. Georges Hospital, Port Elizabeth

6009

Sir Charles Gairdner Hospital, Nedlands

Mount HospitalOncology, Perth

7001

Royal Hobart Hospital, Hobart

7506

Panorama Medi-Clinic / Panorama Oncology Unit, Cape Town

11619

North-Estonian Regional Hospital, Tallinn

44791

Dermatologie Klinik der Ruhr Universitat Bochum- St. Joseph's Hospital, Bochum

51003

Tartu University Clinics Onkology & Haematology Clinic, Tartu

53105

Klinick fur Dermatolgie, Bonn

61070

Kharkov Postgraduate Medical Academy, Kharkov Regional Clinical Oncology Center, Kharkiv

65055

Odessa Regional Oncology DispensaryChemotherapy Dept, Odesa

79010

Lviv State Medical University Regional Oncology Centre, Lviv

79104

Universitatsklinikum Freiburg, Freiburg im Breisgau

88000

Uzhgorod Regional Oncology Diepensary, Uzhhorod

D-10117

Klinick fur Dermatologie, Berlin

D-20246

Universitatsklinik Eppendorf, Hamburg

D-24105

Kinkum der Christian-Albrecht-Universitat KielDepartment of Dermatologie, Kiel

D-68135

Klinik fur DermatologieVenerologie und Allergologie, Mannheim

LV-1079

Latvian Onkology Centre, Riga

LT-5808

Klaipeda Hospital, Klaipėda

LT-2600

Vilnius University Onkology Institute, Vilnius

Unknown

Daniel DenHoed Kliniek, Rotterdam

Sandton Oncology Centre, Morningside, Johannesburg

Pretoria Academic Hospital / Department Medical Oncology, Pretoria

Dnipropetrovsk State Medical Academy, Dnipropetrovsk

Royal Marsden Hospital, London

0028

Wilgers Hospital / Wilgers Oncology Centre, Hatfield, Pretoria

0002

Little Company of Mary / Mary Potter Oncology Centre, Pretoria

03022

Scientific Research Institute of OncologySoft Tissue Department, Kiev

B15 2TH

Cancer Centre, Egbaston

M2O 4BX

Christies Hospital, Withington

G11 6NT

Beatson Oncology CentreWestern InfirmaryOncology, Glasgow

LS9 7TF

Cancer Research BldgDivsion of Cancer Medicine Research, Leeds

NW3 2QG

Roayl Free Hospital, London

SW17 0QT

St. George's Hospital, London

SW3 6JJ

Royal Marsden Hospital Department of Oncology, London

NE4 6BE

Newcastle GeneralOncology, Newcastle

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

ICON Clinical Research

INDUSTRY

lead

Celgene

INDUSTRY